Cite
HARVARD Citation
Pohlmeyer, C. et al. (n.d.). AB0484 Monotherapy with filgotinib, a jak1-selective inhibitor, reduces disease severity and alters immune cell subsets in the nzb/w f1 murine model of lupus. Annals of the rheumatic diseases. p. 1403. [Online].